NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|8131850|gb|AAF73106|]
View 

aminopeptidase PILS [Rattus norvegicus]

Protein Classification

M1 family metallopeptidase( domain architecture ID 10176184)

M1 family metallopeptidase containing an ERAP1-like C-terminal domain with HEAT-like repeats is a zinc-dependent metallopeptidase with an HEXXH motif as part of its active site, similar to aminopeptidase N, a broad specificity aminopeptidase, and glutamyl aminopeptidase, which releases N-terminal glutamate from a peptide

EC:  3.4.11.-
Gene Ontology:  GO:0008237|GO:0008270|GO:0006508
MEROPS:  M1

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
50-515 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


:

Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 635.00  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   50 IHYDLMIHANLSTLTFWGKTEVEITVSQPTSTIIMHSHQLQISKATLRRGAEEmlPEEPLKLMEYSAHEQVALLTAQPLL 129
Cdd:cd09601   1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGS--GIIEVTVVTDEETEFLTITLDETLP 78
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  130 AGSVYTVIITYAANLSENFHGFYKSTYRTQEGERRILAATQFEPTAARMAFPCFDEPALKASFSIKIKRDPRHLAISNMP 209
Cdd:cd09601  79 PGENYTLSIEFTGKLNDDLRGFYRSSYTDEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNMP 158
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  210 LVKSVTVAEGLIEDHFDITVKMSTYLVAFIISDFKSVSKMTKSGVKVSVYAVPDKINQADYALDAAVTLLEFYEDYFSIP 289
Cdd:cd09601 159 PVESTELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFGIP 238
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  290 YPLPKQDLAAIPDFQSGAMENWGLTTYRESALLYDKEKSSASSKLGITMTVSHELAHQWFGNLVTMEWWNDLWLNEGFAK 369
Cdd:cd09601 239 YPLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFAT 318
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  370 FMEFVSVTVTHPELKVEEYFF-GKCFNAMEVDALNSSHPVSTPVENPAQIREMFDEVSYEKGACILNMLRDYLSADTFKR 448
Cdd:cd09601 319 YMEYLAVDKLFPEWNMWDQFVvDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRK 398
                       410       420       430       440       450       460
                ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 8131850  449 GIVQYLQKYSYKNTKNEDLWNSMmhicptdgtqtmdgfcsrNQHSSSTSHwrqevIDIKSMMNTWTL 515
Cdd:cd09601 399 GLRKYLKKHAYGNATTDDLWEAL------------------QEASGESKP-----LDVKEIMDSWTL 442
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
586-905 8.82e-90

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


:

Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 288.40  E-value: 8.82e-90
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    586 WIKFNVGMNGYYIVHYGDDGWASLNGLLkeAHTTISSNDRASLINNAFQLVSIGKLSIEKALDLILYLKNETEIMPIFQG 665
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQL--LSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    666 LNELIPMYKLMEKRDMVEvetQFKDFLLRLLKDLINKQTWTDEG--SVSERMLRSQLLLLACVHRYQLCVQRAERYFREW 743
Cdd:pfam11838  79 LSQLSTLRSLLSADPEYE---ALKAFLRKLLSPLAEKLGWEAPPgeSHLDRQLRALLLSAACSAGDPECVAEAKKLFDAW 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    744 KasNGNMSLPIDVTLAVFAVGAQNT--EGWDFLYSKYQSSLSSTEKSQIEFSLCISQDPEKLQWLLDQSFKGEIIKTQEF 821
Cdd:pfam11838 156 L--DGDDAIPPDLRWAVYCAAVANGgeAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQDL 233
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    822 PHILTLIGRNPVGYPLAWKFLKENWNKIVQKFElGSSSIAHMVMGTTNQFSTRARLEEVKGFFSSLKKNGSQlRCVQQTI 901
Cdd:pfam11838 234 RAVIAGLASNPAGRDLAWDFVKENWDALVKRLG-GGSSLGRLVKGLTPSFSTEEELDEVEAFFADKDTPGLR-RALAQAL 311

                  ....
gi 8131850    902 ETIE 905
Cdd:pfam11838 312 ETIR 315
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
50-515 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 635.00  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   50 IHYDLMIHANLSTLTFWGKTEVEITVSQPTSTIIMHSHQLQISKATLRRGAEEmlPEEPLKLMEYSAHEQVALLTAQPLL 129
Cdd:cd09601   1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGS--GIIEVTVVTDEETEFLTITLDETLP 78
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  130 AGSVYTVIITYAANLSENFHGFYKSTYRTQEGERRILAATQFEPTAARMAFPCFDEPALKASFSIKIKRDPRHLAISNMP 209
Cdd:cd09601  79 PGENYTLSIEFTGKLNDDLRGFYRSSYTDEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNMP 158
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  210 LVKSVTVAEGLIEDHFDITVKMSTYLVAFIISDFKSVSKMTKSGVKVSVYAVPDKINQADYALDAAVTLLEFYEDYFSIP 289
Cdd:cd09601 159 PVESTELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFGIP 238
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  290 YPLPKQDLAAIPDFQSGAMENWGLTTYRESALLYDKEKSSASSKLGITMTVSHELAHQWFGNLVTMEWWNDLWLNEGFAK 369
Cdd:cd09601 239 YPLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFAT 318
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  370 FMEFVSVTVTHPELKVEEYFF-GKCFNAMEVDALNSSHPVSTPVENPAQIREMFDEVSYEKGACILNMLRDYLSADTFKR 448
Cdd:cd09601 319 YMEYLAVDKLFPEWNMWDQFVvDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRK 398
                       410       420       430       440       450       460
                ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 8131850  449 GIVQYLQKYSYKNTKNEDLWNSMmhicptdgtqtmdgfcsrNQHSSSTSHwrqevIDIKSMMNTWTL 515
Cdd:cd09601 399 GLRKYLKKHAYGNATTDDLWEAL------------------QEASGESKP-----LDVKEIMDSWTL 442
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
42-589 3.48e-122

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 383.99  E-value: 3.48e-122
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   42 RLPEYITPIHYDLMIHANLSTLTFWGKTEVEITVSQP-TSTIIMHSHQLQISKATLRrgaeemlpEEPLKlmeYSAHEQV 120
Cdd:COG0308  10 YRPPGYDVTHYDLDLDLDPATTRLSGTATITFTATEApLDSLVLDLKGLEVTSVTVD--------GKPLD---FTRDGER 78
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  121 ALLT-AQPLLAGSVYTVIITYAANLSENFHGFYKSTYrtqEGERRILAATQFEPTAARMAFPCFDEPALKASFSIKIKRD 199
Cdd:COG0308  79 LTITlPKPLAPGETFTLEIEYSGKPSNGGEGLYRSGD---PPDGPPYLYTQCEPEGARRWFPCFDHPDDKATFTLTVTVP 155
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  200 PRHLAISNMPLVKSVTVAEGLIEDHFDITVKMSTYLVAFIISDFKSVSKMTKSGVKVSVYAVPDKINQADYALDAAVTLL 279
Cdd:COG0308 156 AGWVAVSNGNLVSETELGDGRTTWHWADTQPIPTYLFALAAGDYAVVEDTFASGVPLRVYVRPGLADKAKEAFESTKRML 235
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  280 EFYEDYFSIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLydKEKSSASSKLGITMTVSHELAHQWFGNLVTMEWWN 359
Cdd:COG0308 236 DFFEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGEKVLA--DETATDADYERRESVIAHELAHQWFGNLVTCADWD 313
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  360 DLWLNEGFAKFMEFVSVTVTHPELKVEEYFFGKCFN-AMEVDALNSSHPVStpVENPAQIREMFDEVSYEKGACILNMLR 438
Cdd:COG0308 314 DLWLNEGFATYMEQLFSEDLYGKDAADRIFVGALRSyAFAEDAGPNAHPIR--PDDYPEIENFFDGIVYEKGALVLHMLR 391
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  439 DYLSADTFKRGIVQYLQKYSYKNTKNEDLWNSMmhicptdgtqtmdgfcsrNQHSSstshwrqevIDIKSMMNTWTLQKG 518
Cdd:COG0308 392 TLLGDEAFRAGLRLYFARHAGGNATTEDFLAAL------------------EEASG---------RDLSAFFDQWLYQAG 444
                       490       500       510       520       530       540       550
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 8131850  519 FPLITITVRGRN-----VHLKQEhymkgsecfPETGSLWHVPLTFITSKSDSVQRFLLKTKTDVIILPEAVeWIKF 589
Cdd:COG0308 445 LPTLEVEYEYDAdgkvtLTLRQT---------PPRPHPFHIPLEVGLLGGKLTARTVLLDGEQTELVAKPD-PVLL 510
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
270-513 1.02e-94

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 297.66  E-value: 1.02e-94
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    270 YALDAAVTLLEFYEDYFSIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLYDKEKSSASSKLGITMTVSHELAHQWF 349
Cdd:pfam01433   1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    350 GNLVTMEWWNDLWLNEGFAKFMEFVSVTVTHPELKV-EEYFFGKCFNAMEVDALNSSHPVSTPVENPAQIREMFDEVSYE 428
Cdd:pfam01433  81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIwEQFLLDEVQNAMARDALDSSHPITQNVNDPSEIDDIFDAIPYE 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    429 KGACILNMLRDYLSADTFKRGIVQYLQKYSYKNTKNEDLWNSMmhicptdgTQTMDGFcsrnqhssstshwrqeviDIKS 508
Cdd:pfam01433 161 KGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDAL--------SEASGPL------------------DVDS 214

                  ....*
gi 8131850    509 MMNTW 513
Cdd:pfam01433 215 FMDTW 219
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
586-905 8.82e-90

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 288.40  E-value: 8.82e-90
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    586 WIKFNVGMNGYYIVHYGDDGWASLNGLLkeAHTTISSNDRASLINNAFQLVSIGKLSIEKALDLILYLKNETEIMPIFQG 665
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQL--LSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    666 LNELIPMYKLMEKRDMVEvetQFKDFLLRLLKDLINKQTWTDEG--SVSERMLRSQLLLLACVHRYQLCVQRAERYFREW 743
Cdd:pfam11838  79 LSQLSTLRSLLSADPEYE---ALKAFLRKLLSPLAEKLGWEAPPgeSHLDRQLRALLLSAACSAGDPECVAEAKKLFDAW 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    744 KasNGNMSLPIDVTLAVFAVGAQNT--EGWDFLYSKYQSSLSSTEKSQIEFSLCISQDPEKLQWLLDQSFKGEIIKTQEF 821
Cdd:pfam11838 156 L--DGDDAIPPDLRWAVYCAAVANGgeAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQDL 233
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    822 PHILTLIGRNPVGYPLAWKFLKENWNKIVQKFElGSSSIAHMVMGTTNQFSTRARLEEVKGFFSSLKKNGSQlRCVQQTI 901
Cdd:pfam11838 234 RAVIAGLASNPAGRDLAWDFVKENWDALVKRLG-GGSSLGRLVKGLTPSFSTEEELDEVEAFFADKDTPGLR-RALAQAL 311

                  ....
gi 8131850    902 ETIE 905
Cdd:pfam11838 312 ETIR 315
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
169-471 1.25e-62

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 227.75  E-value: 1.25e-62
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    169 TQFEPTAARMAFPCFDEPALKASFSIKIKRDPRHLAISNmPLVKSVTVAEGLIEDHFDITVKMSTYLVAFIISDFKSVSK 248
Cdd:TIGR02412 122 TQFEPADARRVFAVFDQPDLKANFKFSVKAPEDWTVISN-SRETDVTPEPADRRWEFPETPKLSTYLTAVAAGPYHSVQD 200
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    249 MTKSgVKVSVYAVPD--KINQADYALDAAVTLLEFYEDYFSIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLydKE 326
Cdd:TIGR02412 201 ESRS-YPLGIYARRSlaQYLDADAIFTITRQGLAFFHRKFGYPYPFKKYDQIFVPEFNAGAMENAGCVTFAENFLH--RA 277
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    327 KSSASSKLGITMTVSHELAHQWFGNLVTMEWWNDLWLNEGFAKFMEfvsvtvTHPELKVEEY------FF--GKCFnAME 398
Cdd:TIGR02412 278 EATRAEKENRAGVILHEMAHMWFGDLVTMRWWNDLWLNESFAEYMG------TLASAEATEYtdawttFAaqGKQW-AYE 350
                         250       260       270       280       290       300       310
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 8131850    399 VDALNSSHPVSTPVENPAQIREMFDEVSYEKGACILNMLRDYLSADTFKRGIVQYLQKYSYKNTKNEDLWNSM 471
Cdd:TIGR02412 351 ADQLPTTHPIVADVADLADALSNFDGITYAKGASVLKQLVAWVGEEAFFAGVNAYFKRHAFGNATLDDLIDSL 423
pepN PRK14015
aminopeptidase N; Provisional
150-457 2.31e-07

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 54.75  E-value: 2.31e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   150 GFYKS--TYRTQ---EGERRIlaaTQFeptaarmafpcFDEPALKASFSIKIKRDPRHLAI--SNMPLVKSVTVAEGLie 222
Cdd:PRK14015 113 GLYRSggMFCTQceaEGFRRI---TYF-----------LDRPDVLARYTVRIEADKAKYPVllSNGNLVESGELPDGR-- 176
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   223 dHF----DITVKMStYLVAFIISDFKSVSK--MTKSG--VKVSVYAVPDKINQADYALDAAVTLLEFYEDYFSIPYplpk 294
Cdd:PRK14015 177 -HWatweDPFPKPS-YLFALVAGDLDVLEDtfTTRSGreVALEIYVEPGNLDKCDHAMDSLKKSMKWDEERFGLEY---- 250
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   295 qDL-----AAIPDFQSGAMENWGLTTYRESALLYDKEksSASSK--LGITMTVSHELAHQWFGNLVTMEWWNDLWLNEGF 367
Cdd:PRK14015 251 -DLdifmiVAVDDFNMGAMENKGLNIFNSKYVLADPE--TATDAdyERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGL 327
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   368 AKF--MEF--------------VSVTVTH--PElkveeyffgkcfnamevDALNSSHPVstpveNPAQIREM--FDEVS- 426
Cdd:PRK14015 328 TVFrdQEFsadlgsravkriedVRVLRAAqfAE-----------------DAGPMAHPV-----RPDSYIEInnFYTATv 385
                        330       340       350
                 ....*....|....*....|....*....|.
gi 8131850   427 YEKGACILNMLRDYLSADTFKRGIVQYLQKY 457
Cdd:PRK14015 386 YEKGAEVIRMLHTLLGEEGFRKGMDLYFERH 416
 
Name Accession Description Interval E-value
M1_APN-Q_like cd09601
Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), ...
50-515 0e+00

Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1); This M1 peptidase family includes eukaryotic and bacterial members: the catalytic domains of aminopeptidase N (APN), aminopeptidase Q (APQ, laeverin), endoplasmic reticulum aminopeptidase 1 (ERAP1) as well as tricorn interacting factor F3. Aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease, preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is considered a marker of differentiation since it is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. ERAP1, also known as endoplasmic reticulum aminopeptidase associated with antigen processing (ERAAP), adipocyte derived leucine aminopeptidase (A-LAP), or aminopeptidase regulating tumor necrosis factor receptor I (THFRI) shedding (ARTS-1), associates with the closely related ER aminopeptidase ERAP2, for the final trimming of peptides within the ER for presentation by MHC class I molecules. ERAP1 is associated with ankylosing spondylitis (AS), an inflammatory arthritis that predominantly affects the spine. ERAP1 also aids in the shedding of membrane-bound cytokine receptors. The tricorn interacting factor F3, together with factors F1 and F2, degrades the tricorn protease products, producing free amino acids, thus completing the proteasomal degradation pathway. F3 is homologous to F2, but not F1, and shows a strong preference for glutamate in the P1' position. APQ, also known as laeverin, is specifically expressed in human embryo-derived extravillous trophoblasts (EVTs) that invade the uterus during early placentation. It cleaves the N-terminal amino acid of various peptides such as angiotensin III, endokinin C, and kisspeptin-10, all expressed in the placenta in large quantities. APN is a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs are also putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341064 [Multi-domain]  Cd Length: 442  Bit Score: 635.00  E-value: 0e+00
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   50 IHYDLMIHANLSTLTFWGKTEVEITVSQPTSTIIMHSHQLQISKATLRRGAEEmlPEEPLKLMEYSAHEQVALLTAQPLL 129
Cdd:cd09601   1 LHYDLTLTPDLENFTFSGSVTITLEVLEPTDTIVLHAKDLTITSASLTLKGGS--GIIEVTVVTDEETEFLTITLDETLP 78
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  130 AGSVYTVIITYAANLSENFHGFYKSTYRTQEGERRILAATQFEPTAARMAFPCFDEPALKASFSIKIKRDPRHLAISNMP 209
Cdd:cd09601  79 PGENYTLSIEFTGKLNDDLRGFYRSSYTDEDGETRYLAATQFEPTDARRAFPCFDEPAFKATFDITITHPKGYTALSNMP 158
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  210 LVKSVTVAEGLIEDHFDITVKMSTYLVAFIISDFKSVSKMTKSGVKVSVYAVPDKINQADYALDAAVTLLEFYEDYFSIP 289
Cdd:cd09601 159 PVESTELEDGWKTTTFETTPPMSTYLVAFVVGDFEYIESTTKSGVPVRVYARPGKIEQGDFALEVAPKILDFYEDYFGIP 238
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  290 YPLPKQDLAAIPDFQSGAMENWGLTTYRESALLYDKEKSSASSKLGITMTVSHELAHQWFGNLVTMEWWNDLWLNEGFAK 369
Cdd:cd09601 239 YPLPKLDLVAIPDFAAGAMENWGLITYRETALLYDPKTSSASDKQRVAEVIAHELAHQWFGNLVTMKWWDDLWLNEGFAT 318
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  370 FMEFVSVTVTHPELKVEEYFF-GKCFNAMEVDALNSSHPVSTPVENPAQIREMFDEVSYEKGACILNMLRDYLSADTFKR 448
Cdd:cd09601 319 YMEYLAVDKLFPEWNMWDQFVvDELQSALELDSLASSHPIEVPVESPSEISEIFDAISYSKGASVLRMLENFLGEEVFRK 398
                       410       420       430       440       450       460
                ....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 8131850  449 GIVQYLQKYSYKNTKNEDLWNSMmhicptdgtqtmdgfcsrNQHSSSTSHwrqevIDIKSMMNTWTL 515
Cdd:cd09601 399 GLRKYLKKHAYGNATTDDLWEAL------------------QEASGESKP-----LDVKEIMDSWTL 442
M1 cd09595
Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 ...
51-471 1.76e-157

Peptidase M1 family includes the catalytic domains of aminopeptidase N and leukotriene A4 hydrolase; The model represents the catalytic domains of M1 peptidase family members including aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). All peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile upon activation during catalysis. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. APN expression is dysregulated in many inflammatory diseases and is enhanced in numerous tumor cells, making it a lead target in the development of anti-cancer and anti-inflammatory drugs. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase in LTA4H is as yet unknown, while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals.


Pssm-ID: 341058 [Multi-domain]  Cd Length: 413  Bit Score: 468.46  E-value: 1.76e-157
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   51 HYDLMIHANLSTLTFWGKTEVEITVSQPTSTIIMHSHQLQISKATLRRGAEEMLPEEPLKlmeysaHEQVALLTaqPLLA 130
Cdd:cd09595   2 HYDLDLDVDFTTKTLNGTETLTVDASQVGRELVLDLVGLTIHSVSVNGAAVDFGEREHYD------GEKLTIPG--PKPP 73
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  131 GSVYTVIITYAANLSENFHGFYKSTYrtqEGERRILAATQFEPTAARMAFPCFDEPALKASFSIKIKRDPRHLAISNMPL 210
Cdd:cd09595  74 GQTFTVRISFEAKPSKNLLGWLWEQT---AGKEKPYLFTQFEATHARRIFPCIDHPAVKATFTVTITTPKKDLLASNGAL 150
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  211 VKSVTVAEGLIEDHFDITVKMSTYLVAFIISDFKSVSKMTKS--GVKVSVYAVPDKINQADYALDAAVTLLEFYEDYFSI 288
Cdd:cd09595 151 VGEETGANGRKTYRFEDTPPIPTYLVAVVVGDLEFKYVTVKSqpRVGLSVYSEPLQVDQAQYAFDATRAALAWFEDYFGG 230
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  289 PYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLYDKEksSASSKLGITMTVSHELAHQWFGNLVTMEWWNDLWLNEGFA 368
Cdd:cd09595 231 PYPLPKYDLLAVPDFNSGAMENPGLITFRTTYLLRSKV--TDTGARSIENVIAHELAHQWFGNLVTMRWWNDLWLNEGFA 308
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  369 KFMEFVSVTVTHPELKVEEYFFGKCFNAMEVDALNSSHPVSTPVENPAQIREMFDEVSYEKGACILNMLRDYLSADTFKR 448
Cdd:cd09595 309 VYYENRIMDATFGTSSRHLDQLSGSSDLNTEQLLEDSSPTSTPVRSPADPDVAYDGVTYAKGALVLRMLEELVGEEAFDK 388
                       410       420
                ....*....|....*....|...
gi 8131850  449 GIVQYLQKYSYKNTKNEDLWNSM 471
Cdd:cd09595 389 GVQAYFNRHKFKNATTDDFIDAL 411
PepN COG0308
Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];
42-589 3.48e-122

Aminopeptidase N, contains DUF3458 domain [Amino acid transport and metabolism];


Pssm-ID: 440077 [Multi-domain]  Cd Length: 609  Bit Score: 383.99  E-value: 3.48e-122
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   42 RLPEYITPIHYDLMIHANLSTLTFWGKTEVEITVSQP-TSTIIMHSHQLQISKATLRrgaeemlpEEPLKlmeYSAHEQV 120
Cdd:COG0308  10 YRPPGYDVTHYDLDLDLDPATTRLSGTATITFTATEApLDSLVLDLKGLEVTSVTVD--------GKPLD---FTRDGER 78
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  121 ALLT-AQPLLAGSVYTVIITYAANLSENFHGFYKSTYrtqEGERRILAATQFEPTAARMAFPCFDEPALKASFSIKIKRD 199
Cdd:COG0308  79 LTITlPKPLAPGETFTLEIEYSGKPSNGGEGLYRSGD---PPDGPPYLYTQCEPEGARRWFPCFDHPDDKATFTLTVTVP 155
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  200 PRHLAISNMPLVKSVTVAEGLIEDHFDITVKMSTYLVAFIISDFKSVSKMTKSGVKVSVYAVPDKINQADYALDAAVTLL 279
Cdd:COG0308 156 AGWVAVSNGNLVSETELGDGRTTWHWADTQPIPTYLFALAAGDYAVVEDTFASGVPLRVYVRPGLADKAKEAFESTKRML 235
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  280 EFYEDYFSIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLydKEKSSASSKLGITMTVSHELAHQWFGNLVTMEWWN 359
Cdd:COG0308 236 DFFEELFGVPYPFDKYDQVAVPDFNFGAMENQGLVTFGEKVLA--DETATDADYERRESVIAHELAHQWFGNLVTCADWD 313
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  360 DLWLNEGFAKFMEFVSVTVTHPELKVEEYFFGKCFN-AMEVDALNSSHPVStpVENPAQIREMFDEVSYEKGACILNMLR 438
Cdd:COG0308 314 DLWLNEGFATYMEQLFSEDLYGKDAADRIFVGALRSyAFAEDAGPNAHPIR--PDDYPEIENFFDGIVYEKGALVLHMLR 391
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  439 DYLSADTFKRGIVQYLQKYSYKNTKNEDLWNSMmhicptdgtqtmdgfcsrNQHSSstshwrqevIDIKSMMNTWTLQKG 518
Cdd:COG0308 392 TLLGDEAFRAGLRLYFARHAGGNATTEDFLAAL------------------EEASG---------RDLSAFFDQWLYQAG 444
                       490       500       510       520       530       540       550
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 8131850  519 FPLITITVRGRN-----VHLKQEhymkgsecfPETGSLWHVPLTFITSKSDSVQRFLLKTKTDVIILPEAVeWIKF 589
Cdd:COG0308 445 LPTLEVEYEYDAdgkvtLTLRQT---------PPRPHPFHIPLEVGLLGGKLTARTVLLDGEQTELVAKPD-PVLL 510
Peptidase_M1 pfam01433
Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ ...
270-513 1.02e-94

Peptidase family M1 domain; Members of this family are aminopeptidases. The members differ widely in specificity, hydrolysing acidic, basic or neutral N-terminal residues. This family includes leukotriene-A4 hydrolase, this enzyme also has an aminopeptidase activity.


Pssm-ID: 426262 [Multi-domain]  Cd Length: 219  Bit Score: 297.66  E-value: 1.02e-94
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    270 YALDAAVTLLEFYEDYFSIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLYDKEKSSASSKLGITMTVSHELAHQWF 349
Cdd:pfam01433   1 YALEITVKLLEFYEDYFNIPYPLPKYDLVALPDFSAGAMENWGLITYRETLLLYDPGNSSTSDKQRVASVIAHELAHQWF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    350 GNLVTMEWWNDLWLNEGFAKFMEFVSVTVTHPELKV-EEYFFGKCFNAMEVDALNSSHPVSTPVENPAQIREMFDEVSYE 428
Cdd:pfam01433  81 GNLVTMKWWDDLWLNEGFATYMEYLGTDALFPEWNIwEQFLLDEVQNAMARDALDSSHPITQNVNDPSEIDDIFDAIPYE 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    429 KGACILNMLRDYLSADTFKRGIVQYLQKYSYKNTKNEDLWNSMmhicptdgTQTMDGFcsrnqhssstshwrqeviDIKS 508
Cdd:pfam01433 161 KGASVLRMLETLLGEEVFQKGLRSYLKKFQYGNATTEDLWDAL--------SEASGPL------------------DVDS 214

                  ....*
gi 8131850    509 MMNTW 513
Cdd:pfam01433 215 FMDTW 219
M1_APN cd09602
Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the ...
47-471 4.57e-90

Peptidase M1 family including aminopeptidase N catalytic domain; This model represents the catalytic domain of bacterial and eukaryotic aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341065 [Multi-domain]  Cd Length: 440  Bit Score: 293.27  E-value: 4.57e-90
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   47 ITPIHYDLmiHANLSTL--TFWGKTEVEITVSQPTSTIIMHSHQLQISKATLRrgaeemlpEEPLKlMEYSAHEQVALlt 124
Cdd:cd09602  13 ISVVSYDL--DLDLTEGaeTFRGTVTIRFTLREPGASLFLDFRGGEVKSVTLN--------GRPLD-PSAFDGERITL-- 79
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  125 aQPLLAGSVYTVIITYAA---NLSENFHGF----YKSTYrtqegerriLAaTQFEPTAARMAFPCFDEPALKASFSIKIK 197
Cdd:cd09602  80 -PGLLKAGENTVVVEFTApysSDGEGLHRFvdpaDGETY---------LY-TLFEPDDARRVFPCFDQPDLKATFTLTVT 148
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  198 RDPRHLAISNMPLVKSVTVAEGLIEdHFDITVKMSTYLVAFIISDFKSVSKmTKSGVKVSVYA---VPDKINQADYALDA 274
Cdd:cd09602 149 APADWTVISNGPETSTEEAGGRKRW-RFAETPPLSTYLFAFVAGPYHRVED-EHDGIPLGLYCresLAEYERDADEIFEV 226
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  275 AVTLLEFYEDYFSIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLYdkEKSSASSKLGITMTVSHELAHQWFGNLVT 354
Cdd:cd09602 227 TKQGLDFYEDYFGIPYPFGKYDQVFVPEFNFGAMENPGAVTFRESYLFR--EEPTRAQRLRRANTILHEMAHMWFGDLVT 304
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  355 MEWWNDLWLNEGFAKFMEFVSVTVTHPELKVEEYFFGKCFN-AMEVDALNSSHPVSTPVENPAQIREMFDEVSYEKGACI 433
Cdd:cd09602 305 MKWWDDLWLNESFADFMAAKALAEATPFTDAWLTFLLRRKPwAYRADQLPTTHPIAQDVPDLEAAGSNFDGITYAKGASV 384
                       410       420       430
                ....*....|....*....|....*....|....*...
gi 8131850  434 LNMLRDYLSADTFKRGIVQYLQKYSYKNTKNEDLWNSM 471
Cdd:cd09602 385 LKQLVALVGEEAFRAGLREYFKKHAYGNATLDDLIAAL 422
ERAP1_C pfam11838
ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 ...
586-905 8.82e-90

ERAP1-like C-terminal domain; This large domain is composed of 16 alpha helices organized as 8 HEAT-like repeats. This domain forms a concave face that faces towards the active site of the peptidase.


Pssm-ID: 463368 [Multi-domain]  Cd Length: 316  Bit Score: 288.40  E-value: 8.82e-90
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    586 WIKFNVGMNGYYIVHYGDDGWASLNGLLkeAHTTISSNDRASLINNAFQLVSIGKLSIEKALDLILYLKNETEIMPIFQG 665
Cdd:pfam11838   1 WVKLNADDTGYYRVNYDPESLAALLEQL--LSKVLSPLDRAGLIDDAFALARAGELSTSDALDLVLAYLNETDYVVWSAA 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    666 LNELIPMYKLMEKRDMVEvetQFKDFLLRLLKDLINKQTWTDEG--SVSERMLRSQLLLLACVHRYQLCVQRAERYFREW 743
Cdd:pfam11838  79 LSQLSTLRSLLSADPEYE---ALKAFLRKLLSPLAEKLGWEAPPgeSHLDRQLRALLLSAACSAGDPECVAEAKKLFDAW 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    744 KasNGNMSLPIDVTLAVFAVGAQNT--EGWDFLYSKYQSSLSSTEKSQIEFSLCISQDPEKLQWLLDQSFKGEIIKTQEF 821
Cdd:pfam11838 156 L--DGDDAIPPDLRWAVYCAAVANGgeAEWDALLERYRDTTSPSEKERALRALAATPDPELLQRALELALDSDEVRNQDL 233
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    822 PHILTLIGRNPVGYPLAWKFLKENWNKIVQKFElGSSSIAHMVMGTTNQFSTRARLEEVKGFFSSLKKNGSQlRCVQQTI 901
Cdd:pfam11838 234 RAVIAGLASNPAGRDLAWDFVKENWDALVKRLG-GGSSLGRLVKGLTPSFSTEEELDEVEAFFADKDTPGLR-RALAQAL 311

                  ....
gi 8131850    902 ETIE 905
Cdd:pfam11838 312 ETIR 315
M1_APN_like cd09603
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly ...
50-467 4.38e-73

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains mostly bacterial and some archaeal M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341066 [Multi-domain]  Cd Length: 410  Bit Score: 246.73  E-value: 4.38e-73
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   50 IHYDLMIHANLSTLTFWGKTEVEITVSQPTSTIIMHSHQLQISKATLRRgaeemlpeEPLKLMEYSAHEqvalLT---AQ 126
Cdd:cd09603   4 LHYDLDLDYDPATKSLSGTATITFRATQDLDSLQLDLVGLTVSSVTVDG--------VPAAFFTHDGDK----LVitlPR 71
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  127 PLLAGSVYTVIITYAAN--LSENFHGFYKSTYRTQEGerrilAATQFEPTAARMAFPCFDEPALKASFSIKIKRDPRHLA 204
Cdd:cd09603  72 PLAAGETFTVTVRYSGKprPAGYPPGDGGGWEEGDDG-----VWTAGQPEGASTWFPCNDHPDDKATYDITVTVPAGLTV 146
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  205 ISNMPLVKSVTVAEGLIEDHFDITVKMSTYLVAFIISDFKSVSKMTKSGVKVSVYAVPDKINQADYALDAAVTLLEFYED 284
Cdd:cd09603 147 VSNGRLVSTTTNGGGTTTWHWKMDYPIATYLVTLAVGRYAVVEDGSGGGIPLRYYVPPGDAAKAKASFARTPEMLDFFEE 226
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  285 YFsIPYPLPKQDLAAIPDFqSGAMENWGLTTYRESALLYDkekssasskLGITMTVSHELAHQWFGNLVTMEWWNDLWLN 364
Cdd:cd09603 227 LF-GPYPFEKYGQVVVPDL-GGGMEHQTATTYGNNFLNGD---------RGSERLIAHELAHQWFGDSVTCADWADIWLN 295
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  365 EGFAKFMEFVsvtvthpelkVEEYFFGK-CFNAMEVDALNSSHPVSTPVENPAQIREMFDEVSYEKGACILNMLRDYLSA 443
Cdd:cd09603 296 EGFATYAEWL----------WSEHKGGAdAYRAYLAGQRQDYLNADPGPGRPPDPDDLFDRDVYQKGALVLHMLRNLLGD 365
                       410       420
                ....*....|....*....|....
gi 8131850  444 DTFKRGIVQYLQKYSYKNTKNEDL 467
Cdd:cd09603 366 EAFFAALRAYLARYAHGNVTTEDF 389
pepN_strep_liv TIGR02412
aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the ...
169-471 1.25e-62

aminopeptidase N, Streptomyces lividans type; This family is a subset of the members of the zinc metallopeptidase family M1 (pfam01433), with a single member characterized in Streptomyces lividans 66 and designated aminopeptidase N. The spectrum of activity may differ somewhat from the aminopeptidase N clade of E. coli and most other Proteobacteria, well separated phylogenetically within the M1 family. The M1 family also includes leukotriene A-4 hydrolase/aminopeptidase (with a bifunctional active site).


Pssm-ID: 274121 [Multi-domain]  Cd Length: 831  Bit Score: 227.75  E-value: 1.25e-62
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    169 TQFEPTAARMAFPCFDEPALKASFSIKIKRDPRHLAISNmPLVKSVTVAEGLIEDHFDITVKMSTYLVAFIISDFKSVSK 248
Cdd:TIGR02412 122 TQFEPADARRVFAVFDQPDLKANFKFSVKAPEDWTVISN-SRETDVTPEPADRRWEFPETPKLSTYLTAVAAGPYHSVQD 200
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    249 MTKSgVKVSVYAVPD--KINQADYALDAAVTLLEFYEDYFSIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLydKE 326
Cdd:TIGR02412 201 ESRS-YPLGIYARRSlaQYLDADAIFTITRQGLAFFHRKFGYPYPFKKYDQIFVPEFNAGAMENAGCVTFAENFLH--RA 277
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    327 KSSASSKLGITMTVSHELAHQWFGNLVTMEWWNDLWLNEGFAKFMEfvsvtvTHPELKVEEY------FF--GKCFnAME 398
Cdd:TIGR02412 278 EATRAEKENRAGVILHEMAHMWFGDLVTMRWWNDLWLNESFAEYMG------TLASAEATEYtdawttFAaqGKQW-AYE 350
                         250       260       270       280       290       300       310
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 8131850    399 VDALNSSHPVSTPVENPAQIREMFDEVSYEKGACILNMLRDYLSADTFKRGIVQYLQKYSYKNTKNEDLWNSM 471
Cdd:TIGR02412 351 ADQLPTTHPIVADVADLADALSNFDGITYAKGASVLKQLVAWVGEEAFFAGVNAYFKRHAFGNATLDDLIDSL 423
Peptidase_M1_N pfam17900
Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from ...
49-235 3.97e-53

Peptidase M1 N-terminal domain; This domain is found at the N-terminus of aminopeptidases from the M1 family.


Pssm-ID: 465557 [Multi-domain]  Cd Length: 186  Bit Score: 183.32  E-value: 3.97e-53
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850     49 PIHYDLMIHANLSTLTFWGKTEVEITVSQPTSTIIMHSHQLQISKATL-RRGAEEMLPEEplKLMEYSAHEQVALLTAQP 127
Cdd:pfam17900   2 PEHYDLDLKIDLKNFTFSGSVTITLQLNNATNVIVLHASDLTIRSISLsDEVTSDGVPAD--FTEDQKDGEKLTIVLPET 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    128 LLAGSVYTVIITYAANLSENFHGFYKSTYrTQEGERRILAATQFEPTAARMAFPCFDEPALKASFSIKIKRDPRHLAISN 207
Cdd:pfam17900  80 LNQTGPYTLEIEYSGELNDSMTGFYRSTY-TDNGEKKVLVTTQFEPTDARSAFPCFDEPSVKATFTISIIHPKDYTALSN 158
                         170       180
                  ....*....|....*....|....*...
gi 8131850    208 MPLVKSVTVAEGLIEDHFDITVKMSTYL 235
Cdd:pfam17900 159 MPVIASEPLENGWVITTFEQTPKMSTYL 186
M1_APN_like cd09604
Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains ...
237-478 1.74e-30

Peptidase M1 family similar to aminopeptidase N catalytic domain; This family contains bacterial M1 peptidases with smilarity to the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341067 [Multi-domain]  Cd Length: 440  Bit Score: 125.85  E-value: 1.74e-30
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  237 AFIISDFKSVSKMTKSGVKVSVYAVPDKINQADYALDAAVTLLEFYEDYFsIPYPLPKQDLAAiPDFQSGAMENWGLTTY 316
Cdd:cd09604 205 AWAASPDFVVDAATVDGVTVNVYYLPENAEAAERALEYAKDALEFFSEKF-GPYPYPELDVVQ-GPFGGGGMEYPGLVFI 282
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  317 resallydkEKSSASSKLGITMTVSHELAHQWFGNLVTmewwND----LWLNEGFAKFMEFVSVTVTHPELKVEEYFFgk 392
Cdd:cd09604 283 ---------GSRLYDPKRSLEGVVVHEIAHQWFYGIVG----NDerrePWLDEGLATYAESLYLEEKYGKEAADELLG-- 347
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  393 cFNAMEVDALNSSHPVSTPVENPAQIREMFDeVSYEKGACILNMLRDYLSADTFKRGIVQYLQKYSYKNTKNEDLWNSMM 472
Cdd:cd09604 348 -RRYYRAYARGPGGPINLPLDTFPDGSYYSN-AVYSKGALFLEELREELGDEAFDKALREYYRRYKFKHPTPEDFFRTAE 425

                ....*.
gi 8131850  473 HICPTD 478
Cdd:cd09604 426 EVSGKD 431
M1_LTA4H cd09599
Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents ...
44-460 2.99e-28

Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain; This model represents the N-terminal catalytic domain of leukotriene A4 hydrolase (LTA4H; E.C. 3.3.2.6) and the close homolog cold-active aminopeptidase (Colwellia psychrerythraea-type peptidase; ColAP), both members of the aminopeptidase M1 family. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity. The two activities occupy different, but overlapping sites. The activity and physiological relevance of the aminopeptidase is poorly understood while the epoxide hydrolase converts leukotriene A4 (LTA4) into leukotriene B4 (LTB4), a potent chemotaxin that is fundamental to the inflammatory response of mammals. It accepts a variety of substrates, including some opioid, di- and tripeptides, as well as chromogenic aminoacyl-p-nitroanilide derivatives. The aminopeptidase activity of LTA4H is possibly involved in the processing of peptides related to inflammation and host defense. Kinetic analysis shows that LTA4H hydrolyzes arginyl tripeptides with high efficiency and specificity, indicating its function as an arginyl aminopeptidase. Thermodynamic characterization using different biophysical methods shows that structurally distinct inhibitors of the LTA4H occupy different regions of the binding site; while some (RB202, ARM1 and SC57461A) bind to the hydrophobic hydrolase side, both bestatin and captopril are located at the hydrophilic peptidase side. LTB4H overexpression is associated with different pathological conditions and diseases such as cystic fibrosis, coronary heart disease, sepsis, shock, connective tissue disease, and chronic obstructive pulmonary disease. It is also overexpressed in certain human cancers, and has been identified as a functionally important target for mediating anticancer properties of resveratrol, a well-known red wine polyphenolic compound with cancer chemopreventive activity.


Pssm-ID: 341062 [Multi-domain]  Cd Length: 442  Bit Score: 119.10  E-value: 2.99e-28
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   44 PEYITPIHYDLMIHANLSTLTFWGKTEVEITVSQP-TSTIIMHSHQLQISKATLRRGAEemlpeeplklMEYSAHEQVAL 122
Cdd:cd09599   8 YDEVRTTHLDLDLTVDFDKKTISGSATLTLEVLQDgADELVLDTRDLDISSVTVNGGKE----------LKFELGPRDPV 77
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  123 LtaqpllaGSVYTVIITYAANLSENFHgfYKSTYRTQEGERRI--LAA------------TQFEPTAARMAFPCFDEPAL 188
Cdd:cd09599  78 L-------GSALTITLPSPLAKGDTFK--VKIEYSTTPQATALqwLTPeqtagkkhpylfTQCQAIHARSLFPCQDTPSV 148
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  189 KASFSIKIKRDPRHLAIsnMPLV-KSVTVAEGLIEDHFDITVKMSTYLVAFIISD--FKSVSKMTksgvkvSVYAVPDKI 265
Cdd:cd09599 149 KSTYSATVTVPKGLTAL--MSALrTGEKEEAGTGTYTFEQPVPIPSYLIAIAVGDleSREIGPRS------GVWAEPSVV 220
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  266 NQADYALDAAVTLLEFYEDYFSiPYP--------LPkqdlaaiPDFQSGAMENWGLTTYRESALLYDKekSSASsklgit 337
Cdd:cd09599 221 DAAAEEFADTEKFLKAAEKLYG-PYVwgrydllvLP-------PSFPYGGMENPCLTFATPTLIAGDR--SLVD------ 284
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  338 mTVSHELAHQWFGNLVTMEWWNDLWLNEGFAKFMEFVSVTVTHPelkvEEYFfgkCFNAM--------EVDALNSSHP-- 407
Cdd:cd09599 285 -VIAHEIAHSWSGNLVTNANWEHFWLNEGFTVYLERRILERLYG----EEYR---QFEAIlgwkdlqeSIKEFGEDPPyt 356
                       410       420       430       440       450
                ....*....|....*....|....*....|....*....|....*....|....*.
gi 8131850  408 ---VSTPVENPAqirEMFDEVSYEKGACILNMLRDYLSADTFKRGIVQYLQKYSYK 460
Cdd:cd09599 357 llvPDLKGVDPD---DAFSSVPYEKGFQFLYYLEQLGGREVFDPFLRAYFKKFAFQ 409
M1_APN cd09600
Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the ...
135-481 3.43e-28

Peptidase M1 family, including aminopeptidase N catalytic domain; This model represents the catalytic domain of aminopeptidase N (APN; CD13; alanyl aminopeptidase; EC 3.4.11.2), a type II integral membrane protease belonging to the M1 gluzincin family. It includes bacterial-type alanyl aminopeptidases as well as PfA-M1 aminopeptidase (Plasmodium falciparum-type). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and, in higher eukaryotes, is present in a variety of human tissues and cell types (leukocyte, fibroblast, endothelial and epithelial cells). APN expression is dysregulated in inflammatory diseases such as chronic pain, rheumatoid arthritis, multiple sclerosis, systemic sclerosis, systemic lupus erythematosus, polymyositis/dermatomyosytis and pulmonary sarcoidosis, and is enhanced in tumor cells such as melanoma, renal, prostate, pancreas, colon, gastric and thyroid cancers. It is predominantly expressed on stem cells and on cells of the granulocytic and monocytic lineages at distinct stages of differentiation, thus considered a marker of differentiation. Thus, APN inhibition may lead to the development of anti-cancer and anti-inflammatory drugs. APNs are also present in many pathogenic bacteria and represent potential drug targets. Some APNs have been used commercially, such as one from Lactococcus lactis used in the food industry. APN also serves as a receptor for coronaviruses, although the virus receptor interaction site seems to be distinct from the enzymatic site and aminopeptidase activity is not necessary for viral infection. APNs have also been extensively studied as putative Cry toxin receptors. Cry1 proteins are pore-forming toxins that bind to the midgut epithelial cell membrane of susceptible insect larvae, causing extensive damage. Several different toxins, including Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ba, Cry1Ca and Cry1Fa, have been shown to bind to APNs; however, a direct role of APN in cytotoxicity has been yet to be firmly established.


Pssm-ID: 341063 [Multi-domain]  Cd Length: 434  Bit Score: 118.77  E-value: 3.43e-28
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  135 TVIITYAANLSenFHGFYKS--TYRTQ---EGERRIlaaTQFeptaarmafpcFDEPALKASFSIKIKRDPRHLAI--SN 207
Cdd:cd09600  88 EVRINPAANTS--LEGLYKSggILCTQceaEGFRRI---TYF-----------PDRPDVMSKFTVTIEADKEKYPVllSN 151
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  208 MPLVKSVTVAEGLI----EDHFditvKMSTYLVAFIISDFKSVSK--MTKSG--VKVSVYAVPDKINQADYALDAAVTLL 279
Cdd:cd09600 152 GNLIEEGELPNGRHfavwEDPF----PKPSYLFALVAGDLGSVEDtfTTKSGrkVKLRIYVEPGNEDKCHHAMESLKKAM 227
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  280 EFYEDYFSIPYPLPKQDLAAIPDFQSGAMENWGLTTYRESALLYDKEKSSASSKLGITMTVSHELAHQWFGNLVTMEWWN 359
Cdd:cd09600 228 KWDEERFGLEYDLDLFNIVAVDDFNMGAMENKGLNIFNSKYVLADPETATDADYERIESVIAHEYFHNWTGNRVTCRDWF 307
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  360 DLWLNEGFAKF--MEFvSVTVTHPELK-VEEYFFGKCFNAMEvDALNSSHPVstpveNPAQIREM--FDEVS-YEKGACI 433
Cdd:cd09600 308 QLSLKEGLTVFrdQEF-SADMNSRAVKrIEDVRRLRSAQFPE-DAGPMAHPI-----RPDSYIEInnFYTVTvYEKGAEV 380
                       330       340       350       360
                ....*....|....*....|....*....|....*....|....*...
gi 8131850  434 LNMLRDYLSADTFKRGIVQYLQKYSYKNTKNEDLWNSMMHICPTDGTQ 481
Cdd:cd09600 381 IRMLHTLLGEEGFRKGMDLYFERHDGQAVTCEDFVAAMEDASGRDLSQ 428
leuko_A4_hydro TIGR02411
leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive ...
169-460 3.02e-23

leukotriene A-4 hydrolase/aminopeptidase; Members of this family represent a distinctive subset within the zinc metallopeptidase family M1 (pfam01433). The majority of the members of pfam01433 are aminopeptidases, but the sequences in this family for which the function is known are leukotriene A-4 hydrolase. A dual epoxide hydrolase and aminopeptidase activity at the same active site is indicated. The physiological substrate for aminopeptidase activity is not known.


Pssm-ID: 274120 [Multi-domain]  Cd Length: 602  Bit Score: 105.24  E-value: 3.02e-23
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    169 TQFEPTAARMAFPCFDEPALKASFSIKIKrdprhlaiSNMPLVKSVTVAEGLIEDH----FDITVKMSTYLVAFIISDFK 244
Cdd:TIGR02411 128 SQCQAIHARSLFPCQDTPSVKSTYTAEVE--------SPLPVLMSGIRDGETSNDPgkylFKQKVPIPAYLIAIASGDLA 199
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    245 SvskmTKSGVKVSVYAVPDKINQADYALDAAV-TLLEFYEDyFSIPYPLPKQDLAAIPD-FQSGAMENWGLTTYRESALL 322
Cdd:TIGR02411 200 S----APIGPRSTVYSEPEQLEKCQYEFENDTeKFIKTAED-LIFPYEWGQYDLLVLPPsFPYGGMENPNLTFATPTLIA 274
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850    323 YDKEKSSassklgitmTVSHELAHQWFGNLVTMEWWNDLWLNEGFAKFMEFVSVTVTHPELKVEeyffgkcFNAM----- 397
Cdd:TIGR02411 275 GDRSNVD---------VIAHELAHSWSGNLVTNCSWEHFWLNEGWTVYLERRIIGRLYGEKTRH-------FSALigwgd 338
                         250       260       270       280       290       300
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 8131850    398 ---EVDALNSSHPVSTPVEN--PAQIREMFDEVSYEKGACILNMLRDYLSADT-FKRGIVQYLQKYSYK 460
Cdd:TIGR02411 339 lqeSVKTLGETPEFTKLVVDlkDNDPDDAFSSVPYEKGFNFLFYLEQLLGGPAeFDPFLRHYFKKFAYK 407
M1_like_TAF2 cd09839
TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) ...
172-371 3.87e-09

TATA binding protein (TBP) associated factor 2; This family includes TATA binding protein (TBP) associated factor 2 (TAF2, TBP-associated factor TAFII150, transcription initiation factor TFIID subunit 2, RNA polymerase II TBP-associated factor subunit B), and has homology to the M1 gluzincin family. TAF2 is part of the TFIID multidomain subunit complex essential for transcription of most protein-encoded genes by RNA polymerase II. TAF2 is known to interact with the initiator element (Inr) found at the transcription start site of many genes, thus possibly playing a key role in promoter binding as well as start-site selection. Image analysis has shown TAF2 to form a complex with TAF1 and TBP, inferring its role in promoter recognition. Peptidases in the M1 family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. TAF2, however, lacks these active site residues.


Pssm-ID: 341074 [Multi-domain]  Cd Length: 531  Bit Score: 60.32  E-value: 3.87e-09
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  172 EPTAARMAFPCFDEPALKASFSIKIK--RDPRHLAISNMPLVKSVTVAEGLIED-------------------------- 223
Cdd:cd09839 172 LPGSARCWFPCVDSLWERCTWELEITvpRTLGDAGRPPLAGSKEDEDDDDLTEEdkelemvvvcsgdlveqvvhpedpsk 251
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  224 ---HFDITVKMSTYLVAFIISDFKSVS-----------KMTKSGVKVSVYAVPDKINQADYALDAAVTLLEFYEDYFSiP 289
Cdd:cd09839 252 ktfSFSLSNPTSAQHIGFAVGPFEIVPlpefreseeddKLGSSAVEVTGFCLPGRLEELRNTCSFLHKAMDFFEEEYG-S 330
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850  290 YPLP--KQ----DLAAipDFQSGAmenwGLTTYrESALLY-----DKEKSSassklgiTMTVSHELAHQWFGNLVTMEWW 358
Cdd:cd09839 331 YPFSsyKQvfvdDLPE--DVSSFA----SLSIC-SSRLLYppdiiDQAYET-------RRKLAHALASQWFGINIIPKTW 396
                       250
                ....*....|...
gi 8131850  359 NDLWLNEGFAKFM 371
Cdd:cd09839 397 SDTWLVIGIAGYM 409
pepN PRK14015
aminopeptidase N; Provisional
150-457 2.31e-07

aminopeptidase N; Provisional


Pssm-ID: 237585 [Multi-domain]  Cd Length: 875  Bit Score: 54.75  E-value: 2.31e-07
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   150 GFYKS--TYRTQ---EGERRIlaaTQFeptaarmafpcFDEPALKASFSIKIKRDPRHLAI--SNMPLVKSVTVAEGLie 222
Cdd:PRK14015 113 GLYRSggMFCTQceaEGFRRI---TYF-----------LDRPDVLARYTVRIEADKAKYPVllSNGNLVESGELPDGR-- 176
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   223 dHF----DITVKMStYLVAFIISDFKSVSK--MTKSG--VKVSVYAVPDKINQADYALDAAVTLLEFYEDYFSIPYplpk 294
Cdd:PRK14015 177 -HWatweDPFPKPS-YLFALVAGDLDVLEDtfTTRSGreVALEIYVEPGNLDKCDHAMDSLKKSMKWDEERFGLEY---- 250
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   295 qDL-----AAIPDFQSGAMENWGLTTYRESALLYDKEksSASSK--LGITMTVSHELAHQWFGNLVTMEWWNDLWLNEGF 367
Cdd:PRK14015 251 -DLdifmiVAVDDFNMGAMENKGLNIFNSKYVLADPE--TATDAdyERIESVIAHEYFHNWTGNRVTCRDWFQLSLKEGL 327
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 8131850   368 AKF--MEF--------------VSVTVTH--PElkveeyffgkcfnamevDALNSSHPVstpveNPAQIREM--FDEVS- 426
Cdd:PRK14015 328 TVFrdQEFsadlgsravkriedVRVLRAAqfAE-----------------DAGPMAHPV-----RPDSYIEInnFYTATv 385
                        330       340       350
                 ....*....|....*....|....*....|.
gi 8131850   427 YEKGACILNMLRDYLSADTFKRGIVQYLQKY 457
Cdd:PRK14015 386 YEKGAEVIRMLHTLLGEEGFRKGMDLYFERH 416
GluZincin cd09594
Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, ...
335-373 7.66e-05

Gluzincin Peptidase family (thermolysin-like proteinases, TLPs) which includes peptidases M1, M2, M3, M4, M13, M32 and M36 (fungalysins); The Gluzincin family (thermolysin-like peptidases or TLPs) includes several zinc-dependent metallopeptidases such as M1, M2, M3, M4, M13, M32, M36 peptidases (MEROPS classification), which contain the HEXXH motif as part of their active site. Peptidases in this family bind a single catalytic zinc ion which is tetrahedrally co-ordinated by three amino acid ligands and a water molecule that forms the nucleophile on activation during catalysis. The M1 family includes aminopeptidase N (APN) and leukotriene A4 hydrolase (LTA4H). APN preferentially cleaves neutral amino acids from the N-terminus of oligopeptides and is present in a variety of human tissues and cell types. LTA4H is a bifunctional enzyme, possessing an aminopeptidase as well as an epoxide hydrolase activity such that the two activities occupy different, but overlapping sites. The M3_like peptidases include the M2_ACE, M3 or neurolysin-like family (subfamilies M3B_PepF and M3A) and M32_Taq peptidases. The M2 peptidase angiotensin converting enzyme (ACE, EC 3.4.15.1) catalyzes the conversion of decapeptide angiotensin I to the potent vasopressor octapeptide angiotensin II. ACE is a key component of the renin-angiotensin system that regulates blood pressure, thus ACE inhibitors are important for the treatment of hypertension. M3A includes thimet oligopeptidase (TOP; endopeptidase 3.4.24.15), neurolysin (3.4.24.16), and the mitochondrial intermediate peptidase; and M3B includes oligopeptidase F. The M32 family includes eukaryotic enzymes from protozoa Trypanosoma cruzi, a causative agent of Chagas' disease, and from Leishmania major, a parasite that causes leishmaniasis, making these enzymes attractive targets for drug development. The M4 family includes secreted protease thermolysin (EC 3.4.24.27), pseudolysin, aureolysin, and neutral protease as well as bacillolysin (EC 3.4.24.28) that degrade extracellular proteins and peptides for bacterial nutrition, especially prior to sporulation. Thermolysin is widely used as a nonspecific protease to obtain fragments for peptide sequencing as well as in production of the artificial sweetener aspartame. The M13 family includes neprilysin (EC 3.4.24.11) and endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), which fulfill a broad range of physiological roles due to the greater variation in the S2' subsite allowing substrate specificity and are prime therapeutic targets for selective inhibition. The peptidase M36 fungalysin family includes endopeptidases from pathogenic fungi. Fungalysin hydrolyzes extracellular matrix proteins such as elastin and keratin. Aspergillus fumigatus causes the pulmonary disease aspergillosis by invading the lungs of immuno-compromised animals and secreting fungalysin that possibly breaks down proteinaceous structural barriers.


Pssm-ID: 341057 [Multi-domain]  Cd Length: 105  Bit Score: 42.86  E-value: 7.66e-05
                        10        20        30        40
                ....*....|....*....|....*....|....*....|
gi 8131850  335 GITMTVSHELAHQWFGNLVTMEW-WNDLWLNEGFAKFMEF 373
Cdd:cd09594  64 GTIDVLAHELTHAFTGQFSNLMYsWSSGWLNEGISDYFGG 103
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH